Last updated on July 2010

Sufficient Treatment of Peripheral Intervention by Cilostazol


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Arteriosclerosis Obliterans
  • Age: Between 20 - 100 Years
  • Gender: Male or Female
  • Other:
    Patient criteria:
    Chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area*
    Patients who can be monitored for at least 2 years after surgery
    Lesion criteria:
    Angiographically-confirmed new significant superficial femoral artery stenosis or
    occlusive lesions that are 30 cm long or less if stented
    At least 1 arterial runoff below the knee; stenosis lesions not limiting flow may be
    included.
    Occlusive lesions may be included.

You may not be eligible for this study if the following are true:

  • Patients with or at risk of hemorrhagic complications or patients with bleeding
    tendency
    Patients with congestive cardiac failure
    Patients with a drug-eluting stent
    Patients with acute lower limb ischemia
    Patients with creatinine of 2 mg/dL or more(without dialysis)
    patients with a history of serious adverse reaction such as leukopenia, hepatic
    dysfunction, or renal dysfunction, or hypersensitivity to any component of the study
    drug.
    Lesion criteria:
    Remnant inflow
    Severe calcification
    No arterial runoff below the knee

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.